About this document

NN1250-4129 - Protocol-1 0v 29072013 2 by Sindhu is a document available to read on EtoBox.

This document outlines a multi-centre, prospective, open-label, single-arm, non-interventional post marketing surveillance study of Tresiba® (insulin degludec) aimed at evaluating its long-term safety and efficacy in diabetes patients in India. The study will include 1000 patients requiring insulin therapy and will be conducted under routine clinical practice conditions over a duration of one year. The primary objective is to assess the safety of long-term treatment with Tresiba® while collecting relevant s

Author

Sindhu

Language

EN